Berenberg analyst Kerry Holford raised the firm’s price target on Novartis (NVS) to CHF 89 from CHF 86 and keeps a Hold rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- FDA announces expanded use of unannounced inspections at foreign facilities
- Trump to sign order streamlining U.S. drug manufacturing regulations, WaPo says
- Trump urges drugmakers to accept lower prices on prescriptions, Bloomberg says
- BioNTech names Ramon Zapata as CFO, succeeding Jens Holstein
- Biotech Alert: Searches spiking for these stocks today
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue